Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
isopropyl alcohol + bupivacaine hydrochloride + povidone-iodine + dexamethasone sodium
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Parenteral, Topical
01
Overview
This product appears to be a **multi-component procedural anesthetic kit** containing bupivacaine hydrochloride as the principal local anesthetic, dexamethasone sodium as a corticosteroid adjuvant, and povidone-iodine plus isopropyl alcohol as antiseptic skin-preparation components. The intended use is analgesia and anesthesia in the setting of injection or nerve-block procedures: bupivacaine produces prolonged local anesthesia by blocking voltage-gated sodium channels and thereby inhibiting nerve impulse conduction, while dexamethasone is used adjunctively to prolong block duration and reduce local inflammatory responses. Based on the provided context, the exact branded commercial product corresponding to this precise four-ingredient combination could not be definitively identified, so the most accurate annotation is the explicit ingredient-level combination rather than mapping to a related but chemically different kit.
- Other names
- isopropyl alcohol + bupivacaine hydrochloride + povidone-iodine + dexamethasone sodium
02
Targets
GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on isopropyl alcohol + bupivacaine hydrochloride + povidone-iodine + dexamethasone sodium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on isopropyl alcohol + bupivacaine hydrochloride + povidone-iodine + dexamethasone sodium.